2016
Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial
Viscoli CM, Inzucchi SE, Young LH, Insogna KL, Conwit R, Furie KL, Gorman M, Kelly MA, Lovejoy AM, Kernan WN, Investigators F. Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial. The Journal Of Clinical Endocrinology & Metabolism 2016, 102: 914-922. PMID: 27935736, PMCID: PMC5460686, DOI: 10.1210/jc.2016-3237.Peer-Reviewed Original ResearchConceptsTransient ischemic attackIschemic strokeFracture riskBone fracturesRisk/benefit ratioAbsolute fracture riskInsulin Resistance InterventionPlacebo-treated patientsIschemic attackNondiabetic patientsPlacebo groupCardiovascular riskBone healthStroke trialsNondiabetic participantsPrevent fallsClinical trialsRelative riskSafety dataFracture classificationQuarterly interviewsPioglitazonePatientsResistance InterventionRisk increment
1994
Gender difference in prognosis after transient cerebral ischemia or minor stroke
Kernan W, Horwitz R, Brass L, Viscoli C. Gender difference in prognosis after transient cerebral ischemia or minor stroke. Journal Of Stroke And Cerebrovascular Diseases 1994, 4: 148-154. PMID: 26486051, DOI: 10.1016/s1052-3057(10)80177-6.Peer-Reviewed Original ResearchTransient ischemic attackTransient cerebral ischemiaCrude relative riskMinor strokeRelative riskIschemic attackCerebral ischemiaCarotid transient ischemic attacksInitial transient ischemic attackRisk of strokeGender differencesEligible patientsComorbid illnessesPrognostic strataStrokeLarger studyStudy outcomesWomenStatistical significanceMenIschemiaPrognosisRiskEffect of genderDeath